Ipca Laboratories Limited Company Profile | KooCapital.Com

IPCA LABORATORIES LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.

Ipca Laboratories Limited engages in the manufacture, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.

ipca laboratories limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. ipca laboratories limited is SEBI Listed Company (India) and having:-

ISIN (An International Securities Identification Number): INE571A01020
Equity Stock (National Stock Exchange) Symbol: IPCALAB
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=IPCALAB
BSE Link IS: https://www.bseindia.com/stock-share-price/ipca-laboratories-ltd/IPCALAB/524494/

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)

History: [1] Ipca Laboratories Limited is a pharmaceutical company incorporated in 1949. The company was promoted by a group of medical professionals and businessmen and was incorporated under the name

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949.

When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti.

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.

Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

– One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally – 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis – Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy – 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Ipca Laboratories Limited stand with [A dose of life]

Company Website: https://www.ipca.com/
Company Website2: http://www.ipca.com/
LinkedIn page URL: https://in.linkedin.com/company/ipca
Wiki Profile URL: https://en.wikipedia.org/wiki/Ipca_Laboratories

Popular Search Keywords: ipca laboratories limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Major industry

#ipca #laboratories #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry